Persistent babesiosis in a stem cell transplant recipient

被引:18
作者
Lubina, Andrew S. [1 ,2 ]
Snydman, David R. [2 ]
Miller, Kenneth B. [3 ]
机构
[1] Winchester Hosp, Dept Med, Winchester, MA 01890 USA
[2] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA
[3] Tufts Med Ctr, Div Hematol & Oncol, Boston, MA USA
关键词
AZITHROMYCIN; ATOVAQUONE;
D O I
10.1016/j.leukres.2010.11.029
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:E77 / E78
页数:2
相关论文
共 10 条
[1]   Transfusion-associated babesiosis with an atypical time course after nonmyeloablative transplantation for sickle cell disease [J].
Cirino, Christopher M. ;
Leitman, Susan F. ;
Williams, Esther ;
Fedorko, Daniel ;
Palmore, Tara N. ;
Klion, Amy ;
Ockenhouse, Christian ;
Fitzhugh, Courtney ;
Tisdale, John F. ;
Hsieh, Matthew M. .
ANNALS OF INTERNAL MEDICINE, 2008, 148 (10) :794-795
[2]   Absence of erythrocyte sequestration in a case of babesiosis in a splenectomized human patient [J].
Clark, Ian A. ;
Budd, Alison C. ;
Hsue, Gunther ;
Haymore, Bret R. ;
Joyce, Alina J. ;
Thorner, Richard ;
Krause, Peter J. .
MALARIA JOURNAL, 2006, 5 (1)
[3]   Cellular immunity, but not gamma interferon, is essential for resolution of Babesia microti infection in BALB/c mice [J].
Clawson, ML ;
Paciorkowski, N ;
Rajan, TV ;
La Vake, C ;
Pope, C ;
La Vake, M ;
Wikel, SK ;
Krause, PJ ;
Radolf, JD .
INFECTION AND IMMUNITY, 2002, 70 (09) :5304-5306
[4]   Persistent and relapsing babesiosis in Immunocompromised patients [J].
Krause, Peter J. ;
Gewurz, Benjamin E. ;
Hill, David ;
Marty, Francisco M. ;
Vannier, Edouard ;
Foppa, Ivo M. ;
Furman, Richard R. ;
Neuhaus, Ellen ;
Skowron, Gail ;
Gupta, Shaili ;
McCalla, Carlo ;
Pesanti, Edward L. ;
Young, Mary ;
Heiman, Donald ;
Hsue, Gunther ;
Gelfand, Jeffrey A. ;
Wormser, Gary P. ;
Dickason, John ;
Bia, Frank J. ;
Hartman, Barry ;
Telford, Sam R., III ;
Christianson, Diane ;
Dardick, Kenneth ;
Coleman, Morton ;
Girotto, Jennifer E. ;
Spielman, Andrew .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (03) :370-376
[5]   Atovaquone and azithromycin for the treatment of babesiosis. [J].
Krause, PJ ;
Lepore, T ;
Sikand, VK ;
Gadbaw, JJ ;
Burke, G ;
Telford, SR ;
Brassard, P ;
Pearl, D ;
Azlanzadeh, J ;
Christianson, D ;
McGrath, D ;
Spielman, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (20) :1454-1458
[6]   Transfusion-transmitted Babesia microti identified through hemovigilance [J].
Tonnetti, Laura ;
Eder, Anne F. ;
Dy, Beth ;
Kennedy, Jean ;
Pisciotto, Patricia ;
Benjamin, Richard J. ;
Leiby, David A. .
TRANSFUSION, 2009, 49 (12) :2557-2563
[7]  
Vanier E, 2009, INTERDISCIP PER 0827, V2009
[8]   Human babesiosis [J].
Vannier, Edouard ;
Gewurz, Benjamin E. ;
Krause, Peter J. .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2008, 22 (03) :469-+
[9]   The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: Clinical practice guidelines by the infectious diseases society of America [J].
Wormser, Gary P. ;
Dattwyler, Raymond J. ;
Shapiro, Eugene D. ;
Halperin, John J. ;
Steere, Allen C. ;
Klempner, Mark S. ;
Krause, Peter J. ;
Bakken, Johan S. ;
Strle, Franc ;
Stanek, Gerold ;
Bockenstedt, Linda ;
Fish, Durland ;
Dumler, J. Stephen ;
Nadelman, Robert B. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (09) :1089-1134
[10]   Emergence of Resistance to Azithromycin-Atovaquone in Immunocompromised Patients with Babesia microti Infection [J].
Wormser, Gary P. ;
Prasad, Aakanksha ;
Neuhaus, Ellen ;
Joshi, Samit ;
Nowakowski, John ;
Nelson, John ;
Mittleman, Abraham ;
Aguero-Rosenfeld, Maria ;
Topal, Jeffrey ;
Krause, Peter J. .
CLINICAL INFECTIOUS DISEASES, 2010, 50 (03) :381-386